These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2204011)

  • 1. [Acute coronary thrombosis and myocardial ischemia following chemotherapy of Hodgkin's disease].
    Zeymer U; Neuhaus KL
    Onkologie; 1990 Jun; 13(3):221-4. PubMed ID: 2204011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Silent myocardial infarction in a patient treated with radiation therapy and polychemotherapy for Hodgkin's lymphoma].
    Cordioli E; Tondini C; Pizzi C; Massarelli G
    Cardiologia; 1997 Jun; 42(6):635-8. PubMed ID: 9289380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The heparin-induced thrombosis-thrombocytopenia syndrome].
    Erni J; Frey HR; Locher G
    Dtsch Med Wochenschr; 1987 May; 112(20):801-5. PubMed ID: 3569071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery embolism following cancer chemotherapy.
    Ali MK; Ewer MS; Cangir A; Fisher DJ
    Am J Pediatr Hematol Oncol; 1987; 9(3):200-3. PubMed ID: 3674331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage treatment for Hodgkin's disease in relapse.
    Bergsagel DE
    J Clin Oncol; 1987 Apr; 5(4):525-6. PubMed ID: 3549985
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma.
    Küpeli S; Hazirolan T; Varan A; Akata D; Alehan D; Hayran M; Besim A; Büyükpamukçu M
    J Clin Oncol; 2010 Feb; 28(6):1025-30. PubMed ID: 20038721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Aurlien E; Holte H; Pharo A; Kvaløy S; Jakobsen E; Smeland EB; Kvalheim G
    Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe Acute Myocardial Infarction during Induction Chemotherapy for Retroperitoneal Germ Cell Tumor : A Case Report].
    Sakka S; Kawai K; Tsujimoto I; Kurobe M; Ichioka D; Kantori S; Kojima T; Suetomi T; Jouraku A; Miyazaki J; Hoshi T; Nishiyama H
    Hinyokika Kiyo; 2016 Sep; 62(9):483-487. PubMed ID: 27760974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
    Hagemeister FB; Tannir N; McLaughlin P; Salvador P; Riggs S; Velasquez WS; Cabanillas F
    J Clin Oncol; 1987 Apr; 5(4):556-61. PubMed ID: 3559649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of resistant and recurrent lymphoma based on a combination of ifosfamide and etoposide. Antitumor effects, toxicity and stimulation of peripheral stem cells].
    Mayer J; Korístek Z; Vásová I; Müllerová I; Král Z; Navrátil M; Klabusay M; Vorlícek J; Vodvárka P; Hejlová N; Penka M; Krahulcová E; Tomíska M; Adam Z; Hájek R
    Cas Lek Cesk; 1998 Oct; 137(19):590-7. PubMed ID: 9818471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
    Stamatoullas A; Fruchart C; Bastit D; Boulet D; Moncondult M; Piguet H; Tilly H
    Cancer; 1996 Jun; 77(11):2302-7. PubMed ID: 8635099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease].
    Tres A; Fuertes MA; Callén L; Poderós C; Rodrigo G; Peleato A; Polo J; Gutiérrez M
    Rev Esp Oncol; 1984; 31(3):477-82. PubMed ID: 6546176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myocardial infarction with normal coronary arteries in a patient with Hodgkin's disease: a late complication of irradiation and chemotherapy.
    Letsas KP; Korantzopoulos P; Evangelou D; Pappas LK; Kardaras F
    Tex Heart Inst J; 2006; 33(4):512-4. PubMed ID: 17215984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy and chemotherapy for oncological diseases--unappreciated risk factors for coronary artery disease? Acute coronary syndrome in 3 women after radiotherapy and chemotherapy--case reports].
    Wozakowska-Kapłon B; Szymczyk R; Buda S; Biskup P
    Kardiol Pol; 2008 Apr; 66(4):415-9. PubMed ID: 18473270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
    J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thymus hyperplasia after chemotherapy in a case of Hodgkin's disease].
    Andreopoulos D; Klose KC; Glöckner WM
    Rofo; 1991 Oct; 155(4):375-6. PubMed ID: 1718486
    [No Abstract]   [Full Text] [Related]  

  • 17. VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease.
    Ribrag V; Nasr F; Bouhris JH; Bosq J; Brault P; Girinsky T; Cosset JM; Munck JN; Corti C; Decaudin D; Pico JL; Hayat M; Carde P
    Bone Marrow Transplant; 1998 May; 21(10):969-74. PubMed ID: 9632268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subcutaneous inflammatory edema induced by MINE chemotherapy].
    Maubec E; Oberlin O; Belhadj K; Roujeau JC
    Ann Dermatol Venereol; 2001 Apr; 128(4):534-7. PubMed ID: 11395653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
    Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L
    Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line chemotherapy.
    Matsumoto T; Hara T; Shibata Y; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Goto N; Kito Y; Kasahara S; Yamada T; Sawada M; Miyazaki T; Takami T; Takeuchi T; Moriwaki H; Tsurumi H
    Hematol Oncol; 2017 Sep; 35(3):288-295. PubMed ID: 26999778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.